OBJECTIVE: To report an atypical presentation of pH1N1-09 influenza infection in children as fulminant myocarditis and tamponade and the successful treatment with extracorporeal membrane oxygenation. DESIGN: Case report. SETTING: Pediatric cardiac intensive care unit in a quarternary care children's hospital. PATIENTS: Two girls, 5 and 7 yrs of age, infected with pH1N1-09 influenza virus who presented in cardiogenic shock with a pericardial effusion and echocardiographic evidence of tamponade from fulminant myocarditis. INTERVENTIONS: Both patients received a pericardiocentesis. One was managed with multiple, high-dose inotropic agents, whereas the other required institution of extracorporeal membrane oxygenation. MEASUREMENTS AND MAIN RESULTS: Acute respiratory distress syndrome is the major reported clinical manifestation of pH1N1-09 influenza virus infection in hospitalized pediatric patients. In this report we describe two children with confirmed pH1N1-09 influenza infection that required intensive care for fulminant myocarditis. Neither patient had the typical symptoms of influenza-like illness, respiratory compromise, or evidence of pulmonary involvement. One child required extracorporeal membrane oxygenation. Both children survived to hospital discharge. CONCLUSIONS: pH1N1-09 influenza infection can cause fulminant myocarditis in the healthy pediatric population. The clinical presentation may be nonspecific, and the lack of pulmonary symptoms may make diagnosis difficult. Extracorporeal membrane oxygenation support may offer an effective bridge to the recovery of heart function.
OBJECTIVE: To report an atypical presentation of pH1N1-09 influenza infection in children as fulminant myocarditis and tamponade and the successful treatment with extracorporeal membrane oxygenation. DESIGN: Case report. SETTING: Pediatric cardiac intensive care unit in a quarternary care children's hospital. PATIENTS: Two girls, 5 and 7 yrs of age, infected with pH1N1-09 influenza virus who presented in cardiogenic shock with a pericardial effusion and echocardiographic evidence of tamponade from fulminant myocarditis. INTERVENTIONS: Both patients received a pericardiocentesis. One was managed with multiple, high-dose inotropic agents, whereas the other required institution of extracorporeal membrane oxygenation. MEASUREMENTS AND MAIN RESULTS:Acute respiratory distress syndrome is the major reported clinical manifestation of pH1N1-09 influenza virus infection in hospitalized pediatric patients. In this report we describe two children with confirmed pH1N1-09 influenza infection that required intensive care for fulminant myocarditis. Neither patient had the typical symptoms of influenza-like illness, respiratory compromise, or evidence of pulmonary involvement. One child required extracorporeal membrane oxygenation. Both children survived to hospital discharge. CONCLUSIONS: pH1N1-09 influenza infection can cause fulminant myocarditis in the healthy pediatric population. The clinical presentation may be nonspecific, and the lack of pulmonary symptoms may make diagnosis difficult. Extracorporeal membrane oxygenation support may offer an effective bridge to the recovery of heart function.
Authors: Dorothy L Moore; Wendy Vaudry; David W Scheifele; Scott A Halperin; Pierre Déry; Elizabeth Ford-Jones; Haider M Arishi; Barbara J Law; Marc Lebel; Nicole Le Saux; Karen Grimsrud; Theresa Tam Journal: Pediatrics Date: 2006-09 Impact factor: 7.124
Authors: Niranjan Bhat; Jennifer G Wright; Karen R Broder; Erin L Murray; Michael E Greenberg; Maleeka J Glover; Anna M Likos; Drew L Posey; Alexander Klimov; Stephen E Lindstrom; Amanda Balish; Marie-jo Medina; Teresa R Wallis; Jeannette Guarner; Christopher D Paddock; Wun-Ju Shieh; Sherif R Zaki; James J Sejvar; David K Shay; Scott A Harper; Nancy J Cox; Keiji Fukuda; Timothy M Uyeki Journal: N Engl J Med Date: 2005-12-15 Impact factor: 91.245
Authors: Andrew Davies; Daryl Jones; Michael Bailey; John Beca; Rinaldo Bellomo; Nikki Blackwell; Paul Forrest; David Gattas; Emily Granger; Robert Herkes; Andrew Jackson; Shay McGuinness; Priya Nair; Vincent Pellegrino; Ville Pettilä; Brian Plunkett; Roger Pye; Paul Torzillo; Steve Webb; Michael Wilson; Marc Ziegenfuss Journal: JAMA Date: 2009-10-12 Impact factor: 56.272
Authors: Romina Libster; Jimena Bugna; Silvina Coviello; Diego R Hijano; Mariana Dunaiewsky; Natalia Reynoso; Maria L Cavalieri; Maria C Guglielmo; M Soledad Areso; Tomas Gilligan; Fernanda Santucho; Graciela Cabral; Gabriela L Gregorio; Rina Moreno; Maria I Lutz; Alicia L Panigasi; Liliana Saligari; Mauricio T Caballero; Rodrigo M Egües Almeida; Maria E Gutierrez Meyer; Maria D Neder; Maria C Davenport; Maria P Del Valle; Valeria S Santidrian; Guillermina Mosca; Mercedes Garcia Domínguez; Liliana Alvarez; Patricia Landa; Ana Pota; Norma Boloñati; Ricardo Dalamon; Victoria I Sanchez Mercol; Marco Espinoza; Juan Carlos Peuchot; Ariel Karolinski; Miriam Bruno; Ana Borsa; Fernando Ferrero; Angel Bonina; Margarita Ramonet; Lidia C Albano; Nora Luedicke; Elias Alterman; Vilma Savy; Elsa Baumeister; James D Chappell; Kathryn M Edwards; Guillermina A Melendi; Fernando P Polack Journal: N Engl J Med Date: 2009-12-23 Impact factor: 91.245
Authors: Milan Radovanovic; Marija Petrovic; Michel K Barsoum; Charles W Nordstrom; Andrew D Calvin; Igor Dumic; Dorde Jevtic; Richard D Hanna Journal: J Clin Med Date: 2022-07-15 Impact factor: 4.964